Literature DB >> 2372642

Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.

R Koppensteiner1, F Stockenhuber, C Jahn, P Balcke, E Minar, H Ehringer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2372642      PMCID： PMC1663271          DOI： 10.1136/bmj.300.6740.1626

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  A new instrument for the measurement of plasma-viscosity.

Authors:  J HARKNESS
Journal:  Lancet       Date:  1963-08-10       Impact factor: 79.321

2.  Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis.

Authors:  C G Winearls; D O Oliver; M J Pippard; C Reid; M R Downing; P M Cotes
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321
  2 in total
  1 in total

1.  Monthly Continuous Erythropoietin Receptor Activator Versus Weekly Epoetin-Beta, Similar Hemoglobinization but Different Anisocytosis Degree in Hemodialysis Patients: A Randomized Controlled Trial.

Authors:  Miguel G Uriol-Rivera; Aina Obrador-Mulet; Sonia Jimenez-Mendoza; Antonio Corral-Baez; Leonor Perianez-Parraga; Angel Garcia-Alvarez; Francisco J de la Prada
Journal:  J Hematol       Date:  2021-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.